Claim
Strong Support
mechanistic
Analysis v3

TACI signaling promotes the survival of B cells and disrupts immune regulation in both chronic lymphocytic leukemia and systemic lupus erythematosus, contributing to disease development in both...

27
Pro
0
Against

Mechanism

Synthesis from 1 study

How it works

Blocking TACI stops harmful B cells from surviving too long and making antibodies that attack the body. This also fixes the immune system’s ability to tell the difference between real threats and the body’s own tissues, stopping both cancer progression and autoimmune damage at the same time.

Most probable mechanism

In Simple Terms

When TACI is blocked, harmful B cells that survive too long and make damaging antibodies die off, while the immune system regains its ability to distinguish between the body's own tissues and foreign invaders. This stops both cancer growth and autoimmune damage without weakening normal defenses.

Causal chain
1

TACI receptor binding by BAFF or APRIL ligands activates the NF-κB signaling pathway in B cells

Verified by multiple studies
which leads to
2

NF-κB activation increases expression of survival factors, immunosuppressive cytokines (IL-10, TNF), and checkpoint molecules (PD-L1, PD-L2) in pathogenic B cells

Verified by multiple studies
which leads to
3

Elevated immunosuppressive molecules inhibit T-cell function and promote migration of abnormal B cells to lymphoid tissues

Verified by multiple studies
which leads to
4

Sustained TACI signaling enhances germinal center activity and T follicular helper cell expansion, driving autoreactive plasma cell differentiation

Verified by multiple studies
which leads to
5

Blockade of TACI signaling reduces NF-κB activation, leading to decreased survival of pathogenic B cells and loss of immunosuppressive signals

Verified by multiple studies
which leads to
6

Reduced germinal center dysregulation and T follicular helper cell activity normalize B-cell selection and suppress autoantibody production

Verified by multiple studies
which leads to
7

Loss of pathogenic B-cell survival and autoantibody production halts tissue damage and tumor microenvironment formation

Verified by multiple studies

Evidence from Studies

Supporting (1)

27

Community contributions welcome

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict